Misclassification of hospital volume with SEER-Medicare data

被引:0
|
作者
Hollenbeck, Brent K.
Ye, Zaojun
Birkmeyer, John D.
机构
来源
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)30682-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:143 / 143
页数:1
相关论文
共 50 条
  • [41] Overview of the SEER-Medicare data - Content, research applications, and generalizability to the United States elderly population
    Warren, JL
    Klabunde, CN
    Schrag, D
    Bach, PB
    Riley, GF
    MEDICAL CARE, 2002, 40 (08) : 3 - 18
  • [42] Surveillance Patterns and Survival in Hepatocellular Carcinoma: A Seer-medicare Analysis
    Papageorge, Marianna V.
    de Geus, Susanna W.
    Woods, Alison P.
    Ng, Sing Chau
    McAneny, David
    Tseng, Jennifer F.
    Kenzik, Kelly M.
    Sachs, Teviah E.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 391 - 391
  • [43] Patterns of Enteral Feeding Access in Esophagectomy: An Analysis of SEER-Medicare
    Lorimer, Patrick D.
    Walsh, Kendall
    Han, Yimei
    Crimaldi, Anthony J.
    Hill, Joshua S.
    Salo, Jonathan C.
    GASTROENTEROLOGY, 2016, 150 (04) : S1227 - S1227
  • [44] Resected malignant melanoma at high risk of recurrence in SEER-Medicare
    Sadetsky, N.
    Yi, J.
    Hernandez, A.
    Colburn, D.
    Goodman, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Overview of the SEER-Medicare Health Outcomes Survey linked dataset
    Ambs, Anita
    Warren, Joan L.
    Bellizzi, Keith M.
    Topor, Marie
    Haffer, Samuel C.
    Clauser, Steven B.
    HEALTH CARE FINANCING REVIEW, 2008, 29 (04): : 5 - 21
  • [46] Derivation and validation of the SEER-Medicare MDS risk score (SMMRS).
    Uno, Hajime
    Cronin, Angel
    Schrag, Deborah
    Abel, Gregory Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Multispecialty care among hepatocellular carcinoma patients in SEER-Medicare
    Breunig, Ian Michael
    Shaya, Fadia T.
    Mullins, C. Daniel
    Chirikov, Viktor
    Seal, Brian S.
    Hanna, Nader
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Validation of Pancreatic Cancer Diagnosis Claims Within SEER-Medicare
    Ritchey, Mary E.
    He, Jinghua
    Engel, Samuel S.
    Yong, Mellissa
    Brodovicz, Kimberly G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 24 - 24
  • [49] Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data
    Raab, Gabriel T.
    Lin, Aijing
    Hillyer, Grace Clarke
    Keller, Deborah
    O'Neil, Daniel S.
    Accordino, Melissa Kate
    Buono, Donna L.
    Hur, Chin
    Kiran, Ravi P.
    Wright, Jason D.
    Hershman, Dawn L.
    Neugut, Alfred I.
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : E294 - E299
  • [50] Octreotide LAR Among Elderly Patients With Neuroendocrine Tumors: A Survival Analysis of SEER-Medicare Data
    Shen, Chan
    Shih, Ya-Chen Tina
    Xu, Ying
    Yao, James C.
    PANCREAS, 2015, 44 (02) : 358 - 358